<SEC-DOCUMENT>0000896264-25-000144.txt : 20250520
<SEC-HEADER>0000896264-25-000144.hdr.sgml : 20250520
<ACCEPTANCE-DATETIME>20250519182527
ACCESSION NUMBER:		0000896264-25-000144
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250519
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20250520
DATE AS OF CHANGE:		20250519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		25965486

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>usna-20250519.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:80c088a4-b4c3-4c05-b0b3-83b9966e8538,g:2cbdd6ee-3145-418e-a011-edf93e12ee88,d:21ae22ccd0d54f56b14373cb43f591b4-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>usna-20250519</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0000896264</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="usna-20250519.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000896264</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-19</xbrli:startDate><xbrli:endDate>2025-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i21ae22ccd0d54f56b14373cb43f591b4_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of Earliest Event Reported):</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 19, 2025</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">USANA HEALTH SCIENCES, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Utah</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-35024</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">87-0500306</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File No.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3838 West Parkway Boulevard</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Salt Lake City</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Utah</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">84120</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, Zip Code) </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">801</ix:nonNumeric>)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">954-7100</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K &#64257;ling is intended to simultaneously satisfy the &#64257;ling obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.749%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">USNA</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt;text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div id="i21ae22ccd0d54f56b14373cb43f591b4_7"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As reported in Item 5.07 below, at the Annual Meeting the shareholders of USANA Health Sciences, Inc. (the &#8220;Company&#8221;) voted to approve the USANA Health Sciences, Inc. 2025 Equity Incentive Plan (the &#8220;2025 Equity Incentive Plan&#8221;), which had previously been approved by the Board of Directors of the Company (the &#8220;Board&#8221;) on March 27, 2025, subject to approval by the Company&#8217;s shareholders. A description of the material terms of the 2025 Equity Incentive Plan is included in the Proxy Statement under the section titled &#8220;Proposal 2: Approval of the USANA Health Sciences, Inc. 2025 Equity Incentive Plan,&#8221; and is incorporated herein by reference. As further described in the Proxy Statement, the 2025 Equity Incentive Plan was adopted in anticipation of the expiration of the Company&#8217;s 2015 Equity Incentive Award Plan.  No further awards will be granted under the 2015 Plan. An aggregate of 2.5 million shares of the Company&#8217;s common stock have been reserved for issuance under the 2025 Equity Incentive Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description, and the description of the material terms contained in the Proxy Statement, do not purport to be complete and are qualified in their entirety by reference to the full text of the 2025 Equity Incentive Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. Copies of the forms of award agreement, which will be used in connection with awards of performance share units, awards of stock appreciation rights and awards of restricted stock units made under the 2025 Equity Incentive Plan, are attached as Exhibits 10.2, 10.3 and 10.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item&#160;5.07 &#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held its Annual Meeting of Shareholders on May 19, 2025.  A total of 17,387,949 shares (approximately 92%) of the issued and outstanding shares of USANA common stock were represented by proxy or in person at the meeting.  The following matters were submitted and voted upon at the Annual Meeting:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">USANA shareholders voted to elect eight individuals to the Board of Directors for the succeeding year as set forth below: </span></div><div><span><br/></span></div><div style="padding-left:4.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares For</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Withheld</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Abstaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin G. Guest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,073,286</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,544</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Xia Ding </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,672,067</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,763</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John T. Fleming </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,934,541</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,289</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gilbert A. Fuller </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,684,410</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,420</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Scott Nixon, CPA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,933,292</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,538</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peggie J. Pelosi </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,930,541</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,289</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frederic Winssinger </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,877,232</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,598</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy E. Wood, Ph.D. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946,527</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,303</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">USANA shareholders voted to approve the 2025 Equity Incentive Plan as set forth below:</span></div><div style="padding-left:4.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.878%"><tr><td style="width:1.0%"/><td style="width:20.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares For</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Against</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Abstaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,760,276</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,559,134</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,420</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">USANA shareholders voted to ratify the Board&#8217;s selection of KPMG LLP as our independent registered public accounting firm for fiscal year 2025 as set forth below:</span></div><div><span><br/></span></div><div style="padding-left:4.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.030%"><tr><td style="width:1.0%"/><td style="width:20.294%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.217%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares For</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Against</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Abstaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312,686</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,759</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">USANA shareholders voted to approve, on an advisory basis, executive compensation as set forth below:</span></div><div><span><br/></span></div><div style="padding-left:4.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.030%"><tr><td style="width:1.0%"/><td style="width:20.294%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.217%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.255%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares For</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Against</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares Abstaining</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,765,267</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593,966</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,597</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 2.38pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,119</span></td></tr></table></div><div><span><br/></span></div><div id="i21ae22ccd0d54f56b14373cb43f591b4_13"></div><div style="-sec-extract:summary;margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.893%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit</span></div><div style="padding-right:-0.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-0.28pt"><span><br/></span></div><div style="padding-right:-0.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit Description</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.19pt;padding-right:1.19pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a101usanahealthsciencesinc.htm">USANA Health Sciences, Inc. 2025 Equity Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.19pt;padding-right:1.19pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a102formofperformanceshare.htm">Form of Performance Share Unit Agreement under the USANA Health Sciences, Inc. 2025 Equity Incentive Plan </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.19pt;padding-right:1.19pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a103formofstockappreciatio.htm">Form of Stock Appreciation Right Agreement under the USANA Health Sciences, Inc. 2025 Equity Incentive Plan </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.19pt;padding-right:1.19pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a104formofrestrictedstocku.htm">Form of Restricted Stock Unit Agreement under the USANA Health Sciences, Inc. 2025 Equity Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.33pt;padding-right:1.33pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document) </span></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i21ae22ccd0d54f56b14373cb43f591b4_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USANA HEALTH SCIENCES, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By:</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ G. Douglas Hekking </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G. Douglas Hekking, Chief Financial Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 19, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a101usanahealthsciencesinc.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ibb9cb605bf62406290fc59121242ec51_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">USANA HEALTH SCIENCES, INC. 2025 EQUITY INCENTIVE PLAN </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Purpose&#59; Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">General Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The name of this plan is the USANA Health Sciences, Inc. 2025 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The purposes of the Plan are to (a) enable USANA Health Sciences, Inc., a Utah corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and any Affiliate to attract and retain the types of Employees, Consultants and Directors who will contribute to the Company&#8217;s long range success&#59; (b) provide incentives that align the interests of Employees, Consultants and Directors with those of the shareholders of the Company&#59; and (c) promote the success of the Company&#8217;s business.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Eligible Award Recipients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The persons eligible to receive Awards are the Employees, Consultants and Directors of the Company and its Affiliates and such other individuals designated by the Committee who are reasonably expected to become Employees, Consultants and Directors after the receipt of Awards. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Available Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Awards that may be granted under the Plan include&#58; (a) Incentive Stock Options, (b) Non-qualified Stock Options, (c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, (f) Cash Awards, and (g) Other Equity-Based Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a corporation or other entity that, directly or through one or more intermediaries, controls, is controlled by or is under common control with, the Company. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the requirements related to or implicated by the administration of the Plan under applicable state corporate law, United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common Stock are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any right granted under the Plan, including an Incentive Stock Option, a Non-qualified Stock Option, a Stock Appreciation Right, a Restricted Award, a Performance Share Award, a Cash Award, or an Other Equity-Based Award.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a written agreement, contract, certificate or other instrument or document evidencing the terms and conditions of an individual Award granted under the Plan which may, in the discretion of the Company, be transmitted electronically to any Participant. Each Award Agreement shall be subject to the terms and conditions of the Plan. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Beneficial Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of any particular Person, such Person shall be deemed to have beneficial ownership of all securities that such Person has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable only after the passage of time. The terms &#8220;Beneficially Owns&#8221; and &#8220;Beneficially Owned&#8221; have a corresponding meaning. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company, as constituted at any time. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an Award denominated in cash that is granted under <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>10 of the Plan. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means&#58;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to any Employee or Consultant, unless the applicable Award Agreement states otherwise&#58;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;If the Employee or Consultant is a party to an employment or service agreement with the Company or its Affiliates and such agreement provides for a definition of Cause, the definition contained therein&#59; or</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;If no such agreement exists, or if such agreement does not define Cause&#58; (i) the commission of, or plea of guilty or no contest to, a felony or a crime involving moral turpitude or the commission of any other act involving willful malfeasance or material fiduciary breach with respect to the Company or an Affiliate&#59; (ii) conduct that brings or is reasonably likely to bring the Company or an Affiliate negative publicity or into public disgrace, embarrassment, or disrepute&#59; (iii) gross negligence or willful misconduct with respect to the Company or an Affiliate&#59; (iv) material violation of state or federal securities laws&#59; or (v) material violation of the Company&#8217;s written policies or codes of conduct, including written policies related to discrimination, harassment, performance of illegal or unethical activities, and ethical misconduct.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to any Director, unless the applicable Award Agreement states otherwise, a determination by a majority of the disinterested Board members that the Director has engaged in any of the following&#58;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;malfeasance in office&#59;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;gross misconduct or neglect&#59;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;false or fraudulent misrepresentation inducing the director&#8217;s appointment&#59;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;willful conversion of corporate funds&#59; or</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e) &#160;&#160;&#160;&#160;repeated failure to participate in Board meetings on a regular basis despite having received proper notice of the meetings in advance.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has been discharged for Cause.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;One Person (or more than one Person acting as a group) acquires ownership of stock of the Company that, together with the stock held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the stock of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Change in Control shall not occur if any Person (or more than one Person acting as a group) owns more than 50% of the total fair market value or total voting power of the Company&#8217;s stock and acquires additional stock&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;One person (or more than one person acting as a group) acquires (or has acquired during the twelve-month period ending on the date of the most recent acquisition) ownership of the Company&#8217;s stock possessing 30% or more of the total voting power of the stock of such corporation&#59; </font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;A majority of the members of the Board are replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority of the Board before the date of appointment or election&#59; or </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;One person (or more than one person acting as a group), acquires (or has acquired during the twelve-month period ending on the date of the most recent acquisition) assets from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately before such acquisition(s).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall be deemed to include a reference to any regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a committee of one or more members of the Board appointed by the Board to administer the Plan in accordance with <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>3.3 and <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>3.4. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the common stock, $0.001 per share par value per share, of the Company, or such other securities of the Company as may be designated by the Committee from time to time in substitution thereof.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means USANA Health Sciences, Inc. a Utah corporation, and any successor thereto. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any individual or entity which performs bona fide services to the Company or an Affiliate, other than as an Employee or Director, and who may be offered securities registerable pursuant to a registration statement on Form S-8 under the Securities Act.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Consultant or Director, is not interrupted or terminated. The Participant&#8217;s Continuous Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> there is no interruption or termination of the Participant&#8217;s Continuous Service&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if any Award is subject to Section 409A of the Code, this sentence shall only be given effect to the extent consistent with Section 409A of the Code. For example, a change in status from an Employee of the Company to a Director of an Affiliate will not constitute an interruption of Continuous Service. The Committee or its delegate, in its sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other personal or family leave of absence. The Committee or its delegate, in its sole discretion, may determine whether a Company transaction, such as a sale or spin-off of a division or subsidiary </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that employs a Participant, shall be deemed to result in a termination of Continuous Service for purposes of affected Awards, and such decision shall be final, conclusive and binding. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Deferred Stock Units (DSUs)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>8.1(b) hereof.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a member of the Board. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, unless the applicable Award Agreement says otherwise, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for purposes of determining the term of an Incentive Stock Option pursuant to <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>6.10 hereof, the term Disability shall have the meaning ascribed to it under Section 22(e)(3) of the Code. The determination of whether an individual has a Disability shall be determined under procedures established by the Committee. Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option pursuant to <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>6.10 hereof within the meaning of Section 22(e)(3) of the Code, the Committee may rely on any determination that a Participant is disabled for purposes of benefits under any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Disqualifying Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>17.12.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the date that the Company&#8217;s shareholders approve this Plan if such shareholder approval occurs before the first anniversary of the date the Plan is adopted by the Board. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any person, including an Officer or Director, employed by the Company or an Affiliate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, that,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for purposes of determining eligibility to receive Incentive Stock Options, an Employee shall mean an employee of the Company or a parent or subsidiary corporation within the meaning of Section 424 of the Code. Mere service as a Director or payment of a director&#8217;s fee by the Company or an Affiliate shall not be sufficient to constitute &#8220;employment&#8221; by the Company or an Affiliate. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of the Common Stock as determined below. If the Common Stock is listed on any established stock exchange or a national market system, including without limitation, the New York Stock Exchange or the Nasdaq Stock Market, the Fair Market Value shall be the closing price of a share of Common Stock (or if no sales were reported the closing price on the date immediately preceding such date) as quoted on such exchange or system on the day of determination, as reported in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Committee and such determination shall be conclusive and binding on all persons. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s fiscal year.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Free Standing Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>7. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, unless the applicable Award Agreement states otherwise&#58;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;If an Employee or Consultant is a party to an employment or service agreement with the Company or its Affiliates and such agreement provides for a definition of Good Reason, the definition contained therein&#59; or</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;If no such agreement exists or if such agreement does not define Good Reason, the occurrence of one or more of the following without the Participant&#8217;s express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt of a written notice from the Participant describing the applicable circumstances (which notice must be provided by the Participant within ninety (90) days of the Participant&#8217;s knowledge of the applicable circumstances)&#58; (i) any material, adverse change in the Participant&#8217;s duties, responsibilities, authority, title, status or reporting structure&#59; (ii) a material reduction in the Participant&#8217;s base salary or bonus opportunity&#59; or (iii) a geographical relocation of the Participant&#8217;s principal office location by more than fifty (50) miles.  </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution, then such date as is set forth in such resolution. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an Option that is designated by the Committee as an incentive stock option within the meaning of Section 422 of the Code and that meets the requirements set out in the Plan. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Incumbent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means individuals who, on the Effective Date, constitute the Board, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> any individual becoming a Director subsequent to the Effective Date whose election or nomination for election to the Board was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for Director without objection to such nomination) shall be an Incumbent Director. No individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to Directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be an Incumbent Director. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a Director who is a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-qualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an Incentive Stock Option or a Non-qualified Stock Option granted pursuant to the Plan. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optionholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Option Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the price at which a share of Common Stock may be purchased upon the exercise of an Option. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Other Equity-Based Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Award that is not an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, or Performance Share Award that is granted under <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>10 and is payable by delivery of Common Stock and&#47;or which is measured by reference to the value of Common Stock.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an eligible person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon business criteria or other performance measures determined by the Committee in its discretion. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the one or more periods of time not less than one fiscal quarter in duration, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Performance Share Award or a Cash Award. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Share Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Award granted pursuant to <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>9 hereof. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the grant of a right to receive a number of actual shares of Common Stock or share units based upon the performance of the Company during a Performance Period, as determined by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Permitted Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means&#58; (a) a member of the Optionholder&#8217;s immediate family (child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships), any person sharing the Optionholder&#8217;s household (other than a tenant or employee), a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons (or the Optionholder) control the management of assets, and any other entity in which these persons (or the Optionholder) own more than 50% of the voting interests&#59; (b) third parties designated by the Committee in connection with a program established and approved by the Committee pursuant to which Participants may receive a cash payment or other consideration in consideration for the transfer of a Non-qualified Stock Option&#59; and (c) such other transferees as may be permitted by the Committee in its sole discretion.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a person as defined in Section 13(d)(3) of the Exchange Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means this USANA Health Sciences, Inc. 2025 Equity Incentive Plan, as amended and&#47;or amended and restated from time to time.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prior Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the USANA Health Sciences, Inc. 2015 Equity Incentive Award Plan.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Prior Plan Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an award outstanding under the Prior Plan.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>7.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Award granted pursuant to <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>8. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>8. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933, as amended. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the right pursuant to an Award granted under <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>7 to receive, upon exercise, an amount payable in cash or shares equal to the number of shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (a) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (b) the exercise price specified in the Stock Appreciation Right Award Agreement. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Stock for Stock Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>6.4.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Substitute Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">has the meaning set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:none">Section </a>4.6.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Ten Percent Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a person who owns (or is deemed to own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of any of its Affiliates.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Total Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the sum of (a) 2,500,000 shares of Common Stock&#59; plus (b) the number of shares of Common Stock remaining available for issuance under the Prior Plan but not subject to outstanding awards under the Prior Plan as of the Effective Date, plus (c) the number of shares of Common Stock underlying any Prior Plan Award that expires, terminates or is canceled or forfeited under the terms of the Prior Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Authority of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan shall be administered by the Committee or, in the Board&#8217;s sole discretion, by the Board. Subject to the terms of the Plan, the Committee&#8217;s charter and Applicable Laws, and in addition to other express powers and authorization conferred by the Plan, the Committee shall have the authority&#58; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to construe and interpret the Plan and apply its provisions&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to promulgate, amend, and rescind rules and regulations relating to the administration of the Plan&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to delegate its authority to one or more Officers of the Company with respect to Awards that do not involve &#8220;insiders&#8221; within the meaning of Section 16 of the Exchange Act&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to determine when Awards are to be granted under the Plan and the applicable Grant Date&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">from time to time to select, subject to the limitations set forth in this Plan, those eligible Award recipients to whom Awards shall be granted&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to determine the number of shares of Common Stock to be made subject to each Award&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to determine whether each Option is to be an Incentive Stock Option or a Non-qualified Stock Option&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">to prescribe the terms and conditions of each Award, including, without limitation, the exercise price and medium of payment and vesting provisions, and to specify the provisions of the Award Agreement relating to such grant&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">to determine the target number of Performance Shares to be granted pursuant to a Performance Share Award, the performance measures that will be used to establish the Performance Goals, the Performance Period(s) and the number of Performance Shares earned by a Participant&#59; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to amend any outstanding Awards, including for the purpose of modifying the time or manner of vesting, or the term of any outstanding Award&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any such amendment impairs a Participant&#8217;s rights or increases a Participant&#8217;s obligations under his or her Award or creates or increases a Participant&#8217;s federal income tax liability with respect to an Award, such amendment shall also be subject to the Participant&#8217;s consent&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">to determine the duration and purpose of leaves of absences which may be granted to a Participant without constituting termination of their employment for purposes of the Plan, which periods shall be no shorter than the periods generally applicable to Employees under the Company&#8217;s employment policies&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">to make decisions with respect to outstanding Awards that may become necessary upon a change in corporate control or an event that triggers anti-dilution adjustments&#59;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to interpret, administer, reconcile any inconsistency in, correct any defect in and&#47;or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan&#59; and</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to exercise discretion to make any and all other determinations which it determines to be necessary or advisable for the administration of the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee also may modify the purchase price or the exercise price of any outstanding Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if the modification effects a repricing, shareholder approval shall be required before the repricing is effective. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Committee Decisions Final</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All decisions made by the Committee pursuant to the provisions of the Plan shall be final and binding on the Company and the Participants, unless such decisions are determined by a court having jurisdiction to be arbitrary and capricious.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee or, if no Committee has been appointed, the Board may delegate administration of the Plan to a committee or committees of one or more members of the Board, and the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall apply to any person or persons to whom such authority has been delegated. The Committee shall have the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board or the Committee shall thereafter be to the committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. The members of the Committee shall be appointed by and serve at the pleasure of the Board. From time to time, the Board may increase or decrease the size of the Committee, add additional members to, remove members (with or without cause) from, appoint new members in substitution therefor, and fill vacancies, however caused, in the Committee. The Committee shall act pursuant to a vote of the majority of its members or, in the case of a Committee comprised of only two members, the unanimous consent of its members, whether present or not, or by the written consent of the majority of its members and minutes shall be kept of all of its meetings and copies thereof shall be provided to the Board. Subject to the limitations prescribed by the Plan and the Board, the Committee may establish and follow such rules and regulations for the conduct of its business as it may determine to be advisable. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Committee Composition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as otherwise determined by the Board, the Committee shall consist solely of two or more Non-Employee Directors. The Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule 16b-3. However, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section 16 of the Exchange Act, the Committee shall be a compensation committee of the Board that at all times consists solely of two or more Non-Employee Directors. Within the scope of such authority, the Board or the Committee may delegate to a committee of one or more members of the Board who are not Non-Employee Directors the authority to grant Awards to eligible persons who are not then subject to Section 16 of the Exchange Act. Nothing herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under the Plan by a compensation committee of the Board that does not at all times consist solely of two or more Non-Employee Directors.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to such other rights of indemnification as they may have as Directors or members of the Committee, and to the extent allowed by Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including attorney&#8217;s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein, to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any Award granted under the Plan, and against all amounts paid by the Committee in settlement thereof (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the settlement has been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such Committee did not act in good faith and in a manner which such person reasonably believed to be in the best interests of the Company, or in the case of a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">criminal proceeding, had no reason to believe that the conduct complained of was unlawful&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer the Company the opportunity at its own expense to handle and defend such action, suit or proceeding. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Shares Subject to the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Subject to adjustment in accordance with <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>14, Awards may be made under the Plan covering up to the Total Share Reserve. As of the Plan&#8217;s effective date, the Company will cease granting awards under the Prior Plan&#59; however, Prior Plan Awards will remain subject to the terms of the Prior Plan. During the terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Shares of Common Stock available for distribution under the Plan may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Subject to adjustment in accordance with <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>14, no more than 500,000 shares of Common Stock may be issued in the aggregate pursuant to the exercise of Incentive Stock Options (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;ISO Limit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">The maximum number of shares of Common Stock subject to Awards granted during a single Fiscal Year to any Non-Employee Director, together with any cash fees paid to such Non-Employee Director during the Fiscal Year shall not exceed a total value of $500,000 (calculating the value of any Awards based on the grant date fair value for financial reporting purposes).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Any shares of Common Stock subject to an Award that expires or is canceled, forfeited, or terminated without issuance of the full number of shares of Common Stock to which the Award related will again be available for issuance under the Plan. Notwithstanding anything to the contrary contained herein, shares subject to an Award under the Plan shall not again be made available for issuance or delivery under the Plan if such shares are (a) shares tendered in payment of an Option, (b) shares delivered or withheld by the Company to satisfy any tax withholding obligation, or (c) shares covered by a stock-settled Stock Appreciation Right or other Awards that were not issued upon the settlement of the Award. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or with which the Company combines (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Substitute Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Substitute Awards shall not be counted against the Total Share Reserve&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as Incentive Stock Options shall be counted against the ISO limit. Subject to applicable stock exchange requirements, available shares under a shareholder-approved plan of an entity directly or indirectly acquired by the Company or with which the Company combines (as appropriately adjusted to reflect such acquisition or transaction) may be used for Awards under the Plan and shall not count toward the Total Share Limit.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Eligibility for Specific Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Incentive Stock Options may be granted only to Employees. Awards other than Incentive Stock Options may be granted to Employees, Consultants and Directors and those individuals whom the Committee determines are reasonably expected to become Employees, Consultants and Directors following the Grant Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Ten Percent Shareholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A Ten Percent Shareholder shall not be granted an Incentive Stock Option unless the Option Exercise Price is at least 110% of the Fair Market Value of the Common Stock on the Grant Date and the Option is not exercisable after the expiration of five years from the Grant Date. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Option Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Option granted under the Plan shall be evidenced by an Award Agreement. Each Option so granted shall be subject to the conditions set forth in this Section 6, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options shall be separately designated Incentive Stock Options or Non-qualified Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. Notwithstanding the foregoing, the Company shall have no liability to any Participant or any other person if an Option designated as an Incentive Stock Option fails to qualify as such at any time or if an Option is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code and the terms of such Option do not satisfy the requirements of Section 409A of the Code. The provisions of separate Options need not be identical, but each Option shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions&#58; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the provisions of <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>5.2 regarding Ten Percent Shareholders, no Incentive Stock Option shall be exercisable after the expiration of 10 years from the Grant Date. The term of a Non-qualified Stock Option granted under the Plan shall be determined by the Committee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, no Non-qualified Stock Option shall be exercisable after the expiration of 10 years from the Grant Date.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exercise Price of an Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the provisions of <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>5.2 regarding Ten Percent Shareholders, the Option Exercise Price of each Incentive Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exercise Price of a Non-qualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Option Exercise Price of each Non-qualified Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, a Non-qualified Stock Option may be granted with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Option Exercise Price of Common Stock acquired pursuant to an Option shall be paid, to the extent permitted by applicable statutes and regulations, either (a) in cash or by certified or bank check at the time the Option is exercised or (b) in the discretion of the Committee, upon such terms as the Committee shall approve, the Option Exercise Price may be paid&#58; (i) by delivery to the Company of other Common Stock, duly endorsed for transfer to the Company, with a Fair Market Value on the date of delivery equal to the Option Exercise Price (or portion thereof) due for the number of shares being acquired, or by means of attestation whereby the Participant identifies for delivery specific shares of Common Stock that have an aggregate Fair Market Value on the date of attestation equal to the Option Exercise Price (or portion thereof) and receives a number of shares of Common Stock equal to the difference between the number of shares thereby purchased and the number of identified attestation shares of Common Stock (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stock for Stock Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; (ii) a &#8220;cashless&#8221; exercise program established with a broker&#59; (iii) by reduction in the number of shares of Common Stock otherwise deliverable upon exercise of such Option with a Fair Market Value equal to the aggregate Option </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">11</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exercise Price at the time of exercise&#59; (iv) by any combination of the foregoing methods&#59; or (v) in any other form of legal consideration that may be acceptable to the Committee. Unless otherwise specifically provided in the Option, the exercise price of Common Stock acquired pursuant to an Option that is paid by delivery (or attestation) to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid only by shares of the Common Stock of the Company that have been held for more than six months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period for which the Common Stock is publicly traded (i.e., the Common Stock is listed on any established stock exchange or a national market system) an exercise by a Director or Officer that involves or may involve a direct or indirect extension of credit or arrangement of an extension of credit by the Company, directly or indirectly, in violation of Section 402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited with respect to any Award under this Plan. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Transferability of an Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. An Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Transferability of a Non-qualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A Non-qualified Stock Option may, in the sole discretion of the Committee, be transferable to a Permitted Transferee, upon written approval by the Committee to the extent provided in the Award Agreement. If the Non-qualified Stock Option does not provide for transferability, then the Non-qualified Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Vesting of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Option that vests solely based on the continued service of an Employee or Consultant shall vest and therefore become exercisable no earlier than one (1) year after the Grant Date. Each Option that vests based on the achievement of performance or other criteria shall vest and therefore become exercisable no earlier than one (1) year after the Grant Date. For Director Option Awards, each Option shall vest and become exercisable at the time or times set forth on a schedule established by the Committee in the applicable Award Agreement. No Option may be exercised for a fraction of a share of Common Stock. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise provided in an Award Agreement or in an employment agreement the terms of which have been approved by the Committee, in the event an Optionholder&#8217;s Continuous Service terminates (other than upon the Optionholder&#8217;s death or Disability), the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination) but only within such period of time ending on the earlier of (a) the date three months following the termination of the Optionholder&#8217;s Continuous Service or (b) the expiration of the term of the Option as set forth in the Award Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if the termination of Continuous Service is by the Company for Cause, all outstanding Options (whether or not vested) shall immediately terminate and cease to be exercisable. If, after termination, the Optionholder does not exercise his or her Option within the time specified in the Award Agreement, the Option shall terminate. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Extension of Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. An Optionholder&#8217;s Award Agreement may also provide that if the exercise of the Option following the termination of the Optionholder&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">12</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Continuous Service for any reason would be prohibited at any time because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act or any other state or federal securities law or the rules of any securities exchange or interdealer quotation system, then the Option shall terminate on the earlier of (a) the expiration of the term of the Option in accordance with <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>6.1 or (b) the expiration of a period after termination of the Participant&#8217;s Continuous Service that is three months after the end of the period during which the exercise of the Option would be in violation of such registration or other securities law requirements. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Disability of Optionholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise provided in an Award Agreement, in the event that an Optionholder&#8217;s Continuous Service terminates as a result of the Optionholder&#8217;s Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within such period of time ending on the earlier of (a) the date 12 months following such termination or (b) the expiration of the term of the Option as set forth in the Award Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified herein or in the Award Agreement, the Option shall terminate. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Death of Optionholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless otherwise provided in an Award Agreement, in the event an Optionholder&#8217;s Continuous Service terminates as a result of the Optionholder&#8217;s death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder&#8217;s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise the Option upon the Optionholder&#8217;s death, but only within the period ending on the earlier of (a) the date 12 months following the date of death or (b) the expiration of the term of such Option as set forth in the Award Agreement. If, after the Optionholder&#8217;s death, the Option is not exercised within the time specified herein or in the Award Agreement, the Option shall terminate. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Incentive Stock Option $100,000 Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and its Affiliates) exceeds $100,000, the Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Non-qualified Stock Options. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Stock Appreciation Right granted under the Plan shall be evidenced by an Award Agreement. Each Stock Appreciation Right so granted shall be subject to the conditions set forth in this Section 7, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Stock Appreciation Rights may be granted alone (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Free Standing Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or in tandem with an Option granted under the Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Grant Requirements for Related Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. &#160;Any Related Right that relates to a Non-qualified Stock Option may be granted at the same time the Option is granted or at any time thereafter but before the exercise or expiration of the Option. Any Related Right that relates to an Incentive Stock Option must be granted at the same time the Incentive Stock Option is granted.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The term of a Stock Appreciation Right granted under the Plan shall be determined by the Committee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, no Stock Appreciation Right shall be exercisable later than the tenth anniversary of the Grant Date.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Each Stock Appreciation Right that vests solely based on the continued service of an Employees or Consultant shall vest and therefore become exercisable no earlier than one (1) year after the Grant Date. Each Stock Appreciation Right that vests based on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">13</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">achievement of performance or other criteria shall vest and therefore become exercisable no earlier than one (1) year after the Grant Date. For Director Stock Appreciation Right Awards, each Stock Appreciation Right shall vest and become exercisable at the time or times set forth on a schedule established by the Committee in the applicable Award Agreement. No Stock Appreciation Right may be exercised for a fraction of a share of Common Stock.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exercise and Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Upon exercise of a Stock Appreciation Right, the holder shall be entitled to receive from the Company an amount equal to the number of shares of Common Stock subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (i) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (ii) the exercise price specified in the Stock Appreciation Right or related Option. Payment with respect to the exercise of a Stock Appreciation Right shall be made on the date of exercise. Payment shall be made in the form of shares of Common Stock (with or without restrictions as to substantial risk of forfeiture and transferability, as determined by the Committee in its sole discretion), cash or a combination thereof, as determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The exercise price of a Free Standing Right shall be determined by the Committee, but shall not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date of such Stock Appreciation Right. A Related Right granted simultaneously with or subsequent to the grant of an Option and in conjunction therewith or in the alternative thereto shall have the same exercise price as the related Option, shall be transferable only upon the same terms and conditions as the related Option, and shall be exercisable only to the same extent as the related Option&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that a Stock Appreciation Right, by its terms, shall be exercisable only when the Fair Market Value per share of Common Stock subject to the Stock Appreciation Right and related Option exceeds the exercise price per share thereof and no Stock Appreciation Rights may be granted in tandem with an Option unless the Committee determines that the requirements of Section 7.1 are satisfied. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Reduction in the Underlying Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Upon any exercise of a Related Right, the number of shares of Common Stock for which any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised. The number of shares of Common Stock for which a Related Right shall be exercisable shall be reduced upon any exercise of any related Option by the number of shares of Common Stock for which such Option has been exercised.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Restricted Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A Restricted Award is an Award of actual shares of Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or hypothetical Common Stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) having a value equal to the Fair Market Value of an identical number of shares of Common Stock, which may, but need not, provide that such Restricted Award may not be sold, assigned, transferred or otherwise disposed of, pledged or hypothecated as collateral for a loan or as security for the performance of any obligation or for any other purpose for such period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as the Committee shall determine. Each Restricted Award granted under the Plan shall be evidenced by an Award Agreement. Each Restricted Award so granted shall be subject to the conditions set forth in this Section 8, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Restricted Stock and Restricted Stock Units</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each Participant granted Restricted Stock shall execute and deliver to the Company an Award Agreement with respect to the Restricted Stock setting forth the restrictions and other terms and conditions applicable to such Restricted Stock. If the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (A) an escrow agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">14</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">satisfactory to the Committee, if applicable and (B) the appropriate blank stock power with respect to the Restricted Stock covered by such agreement. If a Participant fails to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and stock power, the Award shall be null and void. Subject to the restrictions set forth in the Award, the Participant generally shall have the rights and privileges of a shareholder as to such Restricted Stock, including the right to vote such Restricted Stock and the right to receive dividends. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The terms and conditions of a grant of Restricted Stock Units shall be reflected in an Award Agreement. No shares of Common Stock shall be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of any such Award. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder. The Committee may also grant Restricted Stock Units with a deferral feature, whereby settlement is deferred beyond the vesting date until the occurrence of a future payment date or event set forth in an Award Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Deferred Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). At the discretion of the Committee, each Restricted Stock Unit or Deferred Stock Unit (representing one share of Common Stock) may be credited with an amount equal to the cash and stock dividends paid by the Company in respect of one share of Common Stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Dividend Equivalents shall be paid currently (and in no case later than the end of the calendar year in which the dividend is paid to the holders of the Common Stock or, if later, the 15th day of the third month following the date the dividend is paid to holders of the Common Stock).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Restrictions</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Restricted Stock awarded to a Participant shall be subject to the following restrictions until the expiration of the Restricted Period, and to such other terms and conditions as may be set forth in the applicable Award Agreement&#58; (A) if an escrow arrangement is used, the Participant shall not be entitled to delivery of the stock certificate&#59; (B) the shares shall be subject to the restrictions on transferability set forth in the Award Agreement&#59; (C) the shares shall be subject to forfeiture to the extent provided in the applicable Award Agreement&#59; and (D) to the extent such shares are forfeited, the stock certificates shall be returned to the Company, and all rights of the Participant to such shares and as a shareholder with respect to such shares shall terminate without further obligation on the part of the Company. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Restricted Stock Units and Deferred Stock Units awarded to any Participant shall be subject to (A) forfeiture until the expiration of the Restricted Period, and satisfaction of any applicable Performance Goals during such period, to the extent provided in the applicable Award Agreement, and to the extent such Restricted Stock Units or Deferred Stock Units are forfeited, all rights of the Participant to such Restricted Stock Units or Deferred Stock Units shall terminate without further obligation on the part of the Company and (B) such other terms and conditions as may be set forth in the applicable Award Agreement. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Committee shall have the authority to remove any or all of the restrictions on the Restricted Stock, Restricted Stock Units and Deferred Stock Units whenever it may determine that, by reason of changes in Applicable Laws or other changes in circumstances arising after the date the Restricted Stock or Restricted Stock Units or Deferred Stock Units are granted, such action is appropriate. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Restricted Period for Employees and Consultants shall commence on the Grant Date and end no earlier than one (1) year after the Grant Date. Any Restricted Award that vests based on the achievement of performance or other criteria shall vest no earlier than one (1) year after the Grant Date. The Restricted Period for Directors shall commence on the Grant Date and end at the time or times set forth on a schedule established by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">15</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Committee in the applicable Award Agreement. No Restricted Award may be granted or settled for a fraction of a share of Common Stock. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Delivery of Restricted Stock and Settlement of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>8.2 and the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge, the stock certificate evidencing the shares of Restricted Stock which have not then been forfeited and with respect to which the Restricted Period has expired (to the nearest full share). Upon the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, or at the expiration of the deferral period with respect to any outstanding Deferred Stock Units, the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted Stock Unit or Deferred Stock Unit (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vested Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock for Vested Units. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Period lapsed in the case of Restricted Stock Units, or the delivery date in the case of Deferred Stock Units, with respect to each Vested Unit. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Stock Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Each certificate representing Restricted Stock awarded under the Plan shall bear a legend in such form as the Company deems appropriate. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Performance Share Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Each Performance Share Award granted under the Plan shall be evidenced by an Award Agreement. Each Performance Share Award so granted shall be subject to the conditions set forth in this Section 9, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. The Committee shall have the discretion to determine&#58; (i) the number of shares of Common Stock or stock-denominated units subject to a Performance Share Award granted to any Participant&#59; (ii) the Performance Period applicable to any Award&#59; (iii) the conditions that must be satisfied for a Participant to earn an Award&#59; and (iv) the other terms, conditions and restrictions of the Award. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Earning Performance Share Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The number of Performance Shares earned by a Participant will depend on the extent to which the performance goals established by the Committee are attained within the applicable Performance Period, as determined by the Committee. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Other Equity-Based Awards and Cash Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Committee may grant Other Equity-Based Awards, either alone or in tandem with other Awards, in such amounts and subject to such conditions as the Committee shall determine in its sole discretion. Each Equity-Based Award shall be evidenced by an Award Agreement and shall be subject to such conditions, not inconsistent with the Plan, as may be reflected in the applicable Award Agreement. The Committee may grant Cash Awards in such amounts and subject to such Performance Goals, other vesting conditions, and such other terms as the Committee determines in its discretion. Cash Awards shall be evidenced in such form as the Committee may determine.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Award Agreement shall provide that no shares of Common Stock shall be purchased or sold thereunder unless and until (a) any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel and (b) if required to do so by the Company, the Participant has executed and delivered to the Company a letter of investment intent in such form </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">16</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and containing such provisions as the Committee may require. The Company shall use reasonable efforts to seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that this undertaking shall not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Use of Proceeds from Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Proceeds from the sale of Common Stock pursuant to Awards, or upon exercise thereof, shall constitute general funds of the Company. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Acceleration of Exercisability and Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee shall have the power to accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest in accordance with the Plan in connection with the death or Disability of a Participant, notwithstanding the provisions in the Award stating the time at which it may first be exercised or the time during which it will vest. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in the Plan or an Award Agreement, no Participant shall be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until such Participant has satisfied all requirements for exercise of the Award pursuant to its terms and no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distributions of other rights for which the record date is prior to the date such Common Stock certificate is issued, except as provided in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>14 hereof. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">No Employment or Other Service Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or shall affect the right of the Company or an Affiliate to terminate (a) the employment of an Employee with or without notice and with or without Cause or (b) the service of a Director pursuant to the By-laws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Transfer&#59; Approved Leave of Absence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of the Plan, no termination of employment by an Employee shall be deemed to result from either (a) a transfer of employment to the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another, or (b) an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the Employee&#8217;s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in writing, in either case, except to the extent inconsistent with Section 409A of the Code if the applicable Award is subject thereto. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Withholding Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee, the Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under an Award by any of the following means (in addition to the Company&#8217;s right to withhold from any compensation paid to the Participant by the Company) or by a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">17</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">combination of such means&#58; (a) tendering a cash payment&#59; (b) authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the exercise or acquisition of Common Stock under the Award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no shares of Common Stock are withheld with a value exceeding the maximum amount of tax required to be withheld by law&#59; or (c) delivering to the Company previously owned and unencumbered shares of Common Stock of the Company. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Adjustments Upon Changes in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event of changes in the outstanding Common Stock or in the capital structure of the Company by reason of any stock or extraordinary cash dividend, stock split, reverse stock split, an extraordinary corporate transaction such as any recapitalization, reorganization, merger, consolidation, combination, exchange, or other relevant change in capitalization occurring after the Grant Date of any Award, Awards granted under the Plan and any Award Agreements, the exercise price of Options and Stock Appreciation Rights, the Performance Goals to which Performance Share Awards and Cash Awards are subject, the maximum number of shares of Common Stock subject to all Awards stated in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>4 will be equitably adjusted or substituted, as to the number, price or kind of a share of Common Stock or other consideration subject to such Awards to the extent necessary to preserve the economic intent of such Award. In the case of adjustments made pursuant to this Section 14, unless the Committee specifically determines that such adjustment is in the best interests of the Company or its Affiliates, the Committee shall, in the case of Incentive Stock Options, ensure that any adjustments under this Section 14 will not constitute a modification, extension or renewal of the Incentive Stock Options within the meaning of Section 424(h)(3) of the Code and in the case of Non-qualified Stock Options, ensure that any adjustments under this Section 14 will not constitute a modification of such Non-qualified Stock Options within the meaning of Section 409A of the Code. Any adjustments made under this Section 14 shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule 16b-3 under the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be conclusive and binding for all purposes. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Effect of Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">Unless otherwise provided in an Award Agreement, notwithstanding any provision of the Plan to the contrary&#58;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the event of a Participant&#8217;s termination of Continuous Service without Cause or for Good Reason during the 12-month period following a Change in Control, notwithstanding any provision of the Plan or any applicable Award Agreement to the contrary, all outstanding Options and Stock Appreciation Rights shall become immediately exercisable with respect to 100% of the shares subject to such Options or Stock Appreciation Rights, and&#47;or the Restricted Period shall expire immediately with respect to 100% of the outstanding shares of Restricted Stock or Restricted Stock Units as of the date of the Participant&#8217;s termination of Continuous Service. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">With respect to Performance Share Awards and Cash Awards, in the event of a Participant&#8217;s termination of Continuous Service without Cause or for Good Reason, in either case, within 12 months following a Change in Control, all Performance Goals or other vesting criteria will be deemed achieved at 100% of target levels and all other terms and conditions will be deemed met as of the date of the Participant&#8217;s termination of Continuous Service.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent practicable, any actions taken by the Committee under the immediately preceding clauses (a) and (b) shall occur in a manner and at a time which allows affected Participants the ability to participate in the Change in Control with respect to the shares of Common Stock subject to their Awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">18</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">In addition, in the event of a Change in Control, the Committee may in its discretion and upon at least 10 days&#8217; advance notice to the affected persons, cancel any outstanding Awards and pay to the holders thereof, in cash or stock, or any combination thereof, the value of such Awards based upon the price per share of Common Stock received or to be received by other shareholders of the Company in the event. In the case of any Option or Stock Appreciation Right with an exercise price (or SAR Exercise Price in the case of a Stock Appreciation Right) that equals or exceeds the price paid for a share of Common Stock in connection with the Change in Control, the Committee may cancel the Option or Stock Appreciation Right without the payment of consideration therefor.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to all or substantially all of the assets and business of the Company and its Affiliates, taken as a whole. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Amendment of the Plan and Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Amendment of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board at any time, and from time to time, may amend or terminate the Plan. However, except as provided in <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>14 relating to adjustments upon changes in Common Stock and <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>16.3, no amendment shall be effective unless approved by the shareholders of the Company to the extent shareholder approval is necessary to satisfy any Applicable Laws. At the time of such amendment, the Board shall determine, upon advice from counsel, whether such amendment will be contingent on shareholder approval. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Shareholder Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board may, in its sole discretion, submit any other amendment to the Plan for shareholder approval. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Contemplated Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible Employees, Consultants and Directors with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to Incentive Stock Options or to the nonqualified deferred compensation provisions of Section 409A of the Code and&#47;or to bring the Plan and&#47;or Awards granted under it into compliance therewith. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">No Impairment of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Rights under any Award granted before amendment of the Plan shall not be impaired by any amendment of the Plan unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Amendment of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee at any time, and from time to time, may amend the terms of any one or more Awards&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Committee may not affect any amendment which would otherwise constitute an impairment of the rights under any Award unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Forfeiture Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may specify in an Award Agreement that the Participant&#8217;s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to applicable vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation, confidentiality, or other restrictive covenants that are contained in the Award Agreement or otherwise applicable to the Participant, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">19</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a termination of the Participant&#8217;s Continuous Service for Cause, or other conduct by the Participant that is detrimental to the business or reputation of the Company and&#47;or its Affiliates.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provisions in this Plan, the Company may cancel any Award, require reimbursement of any Award by a Participant, and effect any other right of recoupment of equity or other compensation provided under the Plan in accordance with any Company policies that may be adopted and&#47;or modified from time to time (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#8220;Clawback Policy&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">). In addition, a Participant may be required to repay to the Company previously paid compensation, whether provided pursuant to the Plan or an Award Agreement, in accordance with the Clawback Policy. By accepting an Award, the Participant is agreeing to be bound by the Clawback Policy, as in effect or as may be adopted and&#47;or modified from time to time by the Company in its discretion (including, without limitation, to comply with applicable law or stock exchange listing requirements).</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Other Compensation Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to shareholder approval if such approval is required&#59; and such arrangements may be either generally applicable or applicable only in specific cases. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Sub-Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may from time to time establish sub-plans under the Plan for purposes of satisfying securities, tax or other laws of various jurisdictions in which the Company intends to grant Awards. Any sub-plans shall contain such limitations and other terms and conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of the Plan, but each sub-plan shall apply only to the Participants in the jurisdiction for which the sub-plan was designed.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Deferral of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may establish one or more programs under the Plan to permit selected Participants the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Participant to payment or receipt of shares of Common Stock or other consideration under an Award. The Committee may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the Committee deems advisable for the administration of any such deferral program.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Unfunded Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan shall be unfunded. Neither the Company, the Board nor the Committee shall be required to establish any special or separate fund or to segregate any assets to assure the performance of its obligations under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Recapitalizations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Award Agreement shall contain provisions required to reflect the provisions of <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>14. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon exercise of a right granted under this Plan, the Company shall issue Common Stock or pay any amounts due within a reasonable period of time thereafter. Subject to any statutory or regulatory obligations the Company may otherwise have, for purposes of this Plan, 30 days shall be considered a reasonable period of time. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">No Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan. The Committee shall determine whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Common Stock or whether any fractional shares should be rounded, forfeited or otherwise eliminated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">20</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Award Agreements authorized under the Plan may contain such other provisions not inconsistent with this Plan, including, without limitation, restrictions upon the exercise of Awards, as the Committee may deem advisable. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan is intended to comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the &#8220;short-term deferral period&#8221; as defined in Section 409A of the Code shall not be treated as deferred compensation unless Applicable Laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section 409A of the Code, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6) month period immediately following the Participant&#8217;s termination of Continuous Service shall instead be paid on the first payroll date after the six-month anniversary of the Participant&#8217;s separation from service (or the Participant&#8217;s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any additional tax or penalty on any Participant under Section 409A of the Code and neither the Company nor the Committee will have any liability to any Participant for such tax or penalty.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Disqualifying Dispositions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Participant who shall make a &#8220;disposition&#8221; (as defined in Section 424 of the Code) of all or any portion of shares of Common Stock acquired upon exercise of an Incentive Stock Option within two years from the Grant Date of such Incentive Stock Option or within one year after the issuance of the shares of Common Stock acquired upon exercise of such Incentive Stock Option (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Disqualifying Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be required to immediately advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such shares of Common Stock. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in this Section 17.13, such provision to the extent possible shall be interpreted and&#47;or deemed amended so as to avoid such conflict. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Beneficiary Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Each Participant under the Plan may from time to time name any beneficiary or beneficiaries by whom any right under the Plan is to be exercised in case of such Participant&#8217;s death. Each designation will revoke all prior designations by the same Participant, shall be in a form reasonably prescribed by the Committee and shall be effective only when filed by the Participant in writing with the Company during the Participant&#8217;s lifetime.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The costs of administering the Plan shall be paid by the Company.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any of the provisions of the Plan or any Award Agreement is held to be invalid, illegal or unenforceable, whether in whole or in part, such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions shall not be affected thereby.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Plan Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The headings in the Plan are for purposes of convenience only and are not intended to define or limit the construction of the provisions hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">21</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Non-Uniform Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee&#8217;s determinations under the Plan need not be uniform and may be made by it selectively among persons who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee shall be entitled to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective Award Agreements.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Effective Date of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan shall become effective as of the Effective Date, but no Award shall be exercised (or, in the case of a stock Award, shall be granted) unless and until the Plan has been approved by the shareholders of the Company, which approval shall be within twelve (12) months before or after the date the Plan is adopted by the Board. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Termination or Suspension of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan shall terminate automatically on the tenth anniversary of the Effective Date. No Award shall be granted pursuant to the Plan after such date, but Awards theretofore granted may extend beyond that date. The Board may suspend or terminate the Plan at any earlier date pursuant to <a href="#ibb9cb605bf62406290fc59121242ec51_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>16.1 hereof. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. </font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The law of the State of Utah shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state&#8217;s conflict of law rules. </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:50.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As adopted by the Board of Directors of USANA Health Sciences, Inc. on &#91;&#9679;&#93;.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:50.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As approved by the shareholders of USANA Health Sciences, Inc. on &#91;&#9679;&#93;.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%">22</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a102formofperformanceshare.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i48bbe648c0004f44a8cf3961e483a14d_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE SHARE UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Performance Share Unit Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) by and between by and between USANA Health Sciences, Inc., a Utah corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company has adopted the USANA Health Sciences 2025 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) pursuant to which Performance Share Units may be granted&#59; and</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Committee has determined that it is in the best interests of the Company and its shareholders to grant the award of Performance Share Units provided for herein.</font></div><div style="margin-bottom:12pt;text-indent:21.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Grant of Performance Share Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Pursuant to Section 9 of the Plan, the Company hereby grants to the Grantee an Award for a target number of &#91;&#9679;&#93; Performance Share Units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Target Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Each Performance Share Unit (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) represents the right to receive one share of Common Stock, subject to the terms and conditions set forth in this Agreement and the Plan. The number of PSUs that the Grantee actually earns for the Performance Period (up to a maximum of &#91;&#9679;&#93;) will be determined by the level of achievement of the Performance Goal(s) in accordance with Exhibit I attached hereto. Capitalized terms that are used but not defined herein have the meanings ascribed to them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of this Agreement, the term &#8220;Performance Period&#8221; shall be the period commencing on &#91;&#9679;&#93; and ending on &#91;&#9679;&#93;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Performance Goal(s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The number of PSUs earned by the Grantee for the Performance Period will be determined at the end of the Performance Period based on the level of achievement of the Performance Goal(s) in accordance with Exhibit I. All determinations of whether Performance Goal(s) have been achieved, the number of PSUs earned by the Grantee, and all other matters related to this <a href="#i48bbe648c0004f44a8cf3961e483a14d_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>3 shall be made by the Committee in its sole discretion.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Promptly following completion of the Performance Period (and no later than &#91;thirty (30)&#93; days following the end of the Performance Period), the Committee will review and certify in writing (a) whether, and to what extent, the Performance Goal(s) for the Performance Period have been achieved, and (b) the number of PSUs that the Grantee shall earn, if any, subject to compliance with the requirements of <a href="#i48bbe648c0004f44a8cf3961e483a14d_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>4. Such certification shall be final, conclusive and binding on the Grantee, and on all other persons, to the maximum extent permitted by law.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Vesting of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The PSUs are subject to forfeiture until they vest. Except as otherwise provided herein, the PSUs will vest and become nonforfeitable on the &#91;last day of the Performance Period&#47;date the Committee certifies the achievement of the Performance Goal(s) in accordance with <a href="#i48bbe648c0004f44a8cf3961e483a14d_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>3.2&#47;date that the PSUs are paid in shares of Common Stock&#93;, subject to (a) the achievement of the minimum threshold Performance Goal(s) for payout set forth in Exhibit I attached hereto, and (b) the Grantee&#8217;s Continuous Service from the Grant Date through the &#91;last day of the Performance Period&#47;date that the Committee certifies the achievement of the Performance Goal(s)&#47;date that the PSUs are paid in shares of Common Stock&#93;. The number of PSUs that vest and become payable under this Agreement shall be determined by the Committee based on the level of achievement of the Performance Goal(s) set forth in Exhibit I and shall be rounded to the nearest whole PSU.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Except as otherwise expressly provided in this Agreement, if the Grantee&#8217;s Continuous Service terminates for any reason at any time before all of the Grantee&#8217;s PSUs have vested, the Grantee&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-indent:36pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unvested PSUs shall be automatically forfeited upon such termination of Continuous Service and neither the Company nor any Affiliate shall have any further obligations to the Grantee under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Notwithstanding <a href="#i48bbe648c0004f44a8cf3961e483a14d_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>5.1, if the Grantee&#8217;s Continuous Service terminates during the Performance Period as a result of the Grantee&#8217;s death or Disability, the Grantee will vest on such date in a pro rata portion of the Target Award calculated by multiplying the Target Award by a fraction, the numerator of which equals the number of days that the Grantee was employed during the Performance Period and the denominator of which equals the total number of days in the Performance Period. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Effect of a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If there is a Change in Control during the Performance Period, then in the event of the Grantee&#8217;s termination of Continuous Service without Cause or for Good Reason within twelve (12) months following the effective date of the Change in Control, all outstanding PSUs shall vest at Target Award levels on the date of such termination and shall be paid no later than sixty (60) days following such termination of Continuous Service.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Payment of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Payment in respect of the PSUs earned for the Performance Period shall be made in shares of Common Stock and shall be issued to the Grantee as soon as practicable following the vesting date and in any event within sixty (60) days following the vesting date. The Company shall (a) issue and deliver to the Grantee the number of shares of Common Stock equal to the number of vested PSUs, and (b) enter the Grantee&#8217;s name on the books of the Company as the shareholder of record with respect to the shares of Common Stock delivered to the Grantee.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to any exceptions set forth in this Agreement or the Plan, the PSUs or the rights relating thereto may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee, except by will or the laws of descent and distribution, and upon any such transfer by will or the laws of descent and distribution, the transferee shall hold such PSUs subject to all of the terms and conditions that were applicable to the Grantee immediately prior to such transfer. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Rights as Shareholder&#59; Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Grantee shall not have any rights of a shareholder with respect to the shares of Common Stock underlying the PSUs, including, but not limited to, voting rights and the right to receive or accrue dividends or dividend equivalents. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Upon and following the vesting of the PSUs and the issuance of shares, the Grantee shall be the record owner of the shares of Common Stock underlying the PSUs unless and until such shares are sold or otherwise disposed of, and as record owner shall be entitled to all rights of a shareholder of the Company (including voting and dividend rights). </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Plan nor this Agreement shall confer upon the Grantee any right to be retained in any position, as an Employee, Consultant or Director of the Company. Further, nothing in the Plan or this Agreement shall be construed to limit the discretion of the Company to terminate the Grantee&#8217;s Continuous Service at any time, with or without Cause. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If any change is made to the outstanding Common Stock or the capital structure of the Company, if required, the PSUs shall be adjusted or terminated in any manner as contemplated by Section 14 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Tax Liability and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">The Grantee shall be required to pay to the Company, and the Company shall have the right to deduct from any compensation paid to the Grantee pursuant to the Plan, the amount of any required withholding taxes in respect of the PSUs and to take all such other action as the Committee deems necessary to satisfy all obligations for the payment of such withholding taxes. The Committee may permit the Grantee to satisfy any federal, state or local tax withholding obligation by any of the following means, or by a combination of such means&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">tendering a cash payment&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable or deliverable to the Grantee as a result of the vesting of the PSUs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no shares of Common Stock shall be withheld with a value exceeding the maximum amount of tax required to be withheld by law&#59; or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">delivering to the Company previously owned and unencumbered shares of Common Stock.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other tax-related withholding (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the ultimate liability for all Tax-Related Items is and remains the Grantee&#8217;s responsibility and the Company (a) makes no representation or undertakings regarding the treatment of any Tax-Related Items in connection with the grant, vesting or settlement of the PSUs or the subsequent sale of any shares, and (b) does not commit to structure the PSUs to reduce or eliminate the Grantee&#8217;s liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The issuance and transfer of shares of Common Stock in connection with the PSUs shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Company&#8217;s shares of Common Stock may be listed. No shares of Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Clawback.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In accordance with Section 17.2 of the Plan, by accepting the PSUs, the Grantee acknowledges that the Grantee is fully bound by, and subject to all of the terms and conditions of, the Clawback Policy, and the Grantee agrees to abide by the terms of the Clawback Policy. To the extent that the Board (or, if applicable, the Committee) determines that all or any portion of the PSUs or the shares of Common Stock issued on settlement thereof (or the value of those shares) must be cancelled, forfeited, repaid, or otherwise recovered by the Company, the Grantee shall promptly take whatever action is necessary to effectuate such cancellation, forfeiture, repayment, or recovery. No recovery of all or a portion of the PSUs under the Clawback Policy will be an event giving rise to a right to resign for Good Reason under any agreement with the Company. In the event of any conflict between the terms of the Clawback Policy and the terms of the Plan or this Agreement, the terms of the Clawback Policy shall govern. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the Secretary of the Company at the Company&#8217;s principal corporate offices. Any notice required to be delivered to the Grantee under this Agreement shall be in writing and addressed to the Grantee at the Grantee&#8217;s address as shown in the records of the Company. Either party may designate another address in writing (or by such other method approved by the Company) from time to time.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement will be construed and interpreted in accordance with the laws of the State of Utah without regard to conflict of law principles.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or the Company to the Committee for review. The resolution of such dispute by the Committee shall be final and binding on the Grantee and the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">PSUs Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is subject to the Plan as approved by the Company&#8217;s shareholders. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the Grantee&#8217;s beneficiaries, executors, administrators and the person(s) to whom the PSUs may be transferred by will or the laws of descent or distribution.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Discretionary Nature of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan is discretionary and may be amended, cancelled or terminated by the Company at any time, in its discretion. The grant of the PSUs in this Agreement does not create any contractual right or other right to receive any PSUs or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Grantee&#8217;s employment with the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee has the right to amend, alter, suspend, discontinue or cancel the PSUs, prospectively or retroactively&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, no such amendment shall adversely affect the Grantee&#8217;s material rights under this Agreement without the Grantee&#8217;s consent. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance with Section 409A of the Code. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">No Impact on Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The value of the Grantee&#8217;s PSUs is not part of the Grantee&#8217;s normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance or similar employee benefit.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by facsimile transmission, by electronic mail in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Grantee hereby acknowledges receipt of a copy of the Plan, this Agreement, and the Clawback Policy. The Grantee has read and understands the terms and provisions thereof, and accepts the PSUs subject to all of the terms and conditions of the Plan, this Agreement, and the Clawback Policy The Grantee acknowledges that there may be adverse tax consequences upon the vesting or settlement of the PSUs or disposition of the underlying shares and that the Grantee has been advised to consult a tax advisor prior to such vesting, settlement or disposition.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21pt">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMPANY&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GRANTEE&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT I</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(PERFORMANCE CRITERIA)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a103formofstockappreciatio.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="icb5ebeaff1154e31a7d30f095b70e7ed_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STOCK APPRECIATION RIGHTS AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Stock Appreciation Rights Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of &#91;&#9679;&#93; by and between USANA Health Sciences, Inc., a Utah corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Grant Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Number of SARs&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exercise Price per SAR&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Expiration Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Grant of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company hereby grants to the Participant an aggregate of &#91;&#9679;&#93; stock appreciation rights (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Each SAR entitles the Participant to receive, upon exercise, an amount equal to the excess of (a) the Fair Market Value of a share of Common Stock on the date of exercise, over (b) the Exercise Price (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Appreciation Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The SARs are being granted pursuant to the terms of the Company&#8217;s 2025 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Consideration&#59; Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The grant of the SARs is made in consideration of the services to be rendered by the Participant to the Company and is subject to the terms and conditions of the Plan. Capitalized terms used but not defined herein will have the meaning ascribed to them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Vesting Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The SARs will vest and become exercisable in &#91;four&#93; equal installments on each of the &#91;first, second, third and fourth&#93; anniversaries of the Grant Date. Except as otherwise provided in this Agreement, the unvested SARs will not be exercisable on or after the Participant&#8217;s termination of Continuous Service. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Expiration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The SARs will expire on the Expiration Date set forth above, or earlier as provided in this Agreement or the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Termination of Continuous Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination for Reasons Other Than Cause, Death, Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant&#8217;s Continuous Service is terminated for any reason other than Cause, death or Disability, the Participant may exercise the vested SARs, but only within such period of time ending on the earlier of (a) the date three months following the termination of the Participant&#8217;s Continuous Service or (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant&#8217;s Continuous Service is terminated for Cause, the SARs (whether vested or unvested) shall immediately terminate and cease to be exercisable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination due to Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise the vested SARs, but only within such period of time ending on the earlier of (a) the date that is three years following the Participant&#8217;s termination of Continuous Service or (b) the Expiration Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination due to Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, the vested SARs may be exercised by the Participant&#8217;s estate, by a person who acquired the right to exercise the SARs by bequest or inheritance or by the person designated to exercise the SARs upon the Participant&#8217;s death, but only within the time period ending on the earlier of (a) the date that is three years following the Participant&#8217;s termination of Continuous Service or (b) the Expiration Date.</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">When to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except as otherwise provided in the Plan or this Agreement, the Participant (or in the case of exercise after the Participant&#8217;s death or incapacity, the Participant&#8217;s executor, administrator, heir or legatee, as the case may be) may exercise his or her vested SARs, in whole or in part, at any time after vesting and until the Expiration Date or earlier termination pursuant to <a href="#icb5ebeaff1154e31a7d30f095b70e7ed_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>3 hereof, by following the procedures set forth in this Section 4. If partially exercised, the Participant may exercise the remaining unexercised portion of the SARs at any time after vesting and until the Expiration Date or earlier termination pursuant to <a href="#icb5ebeaff1154e31a7d30f095b70e7ed_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>3 hereof. No SARs shall be exercisable after the Expiration Date. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Election to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To exercise the SARs, the Participant (or in the case of exercise after the Participant&#8217;s death or incapacity, the Participant&#8217;s executor, administrator, heir or legatee, as the case may be) must deliver to the Company a written notice (or notice through another previously approved method, which could include a web-based or e-mail system) to the Secretary of the Company which sets forth the number of SARs being exercised, together with any additional documents the Company may require. Each such notice must satisfy whatever then-current procedures apply to the SARs and must contain such representations as the Company requires.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Documentation of Right to Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If someone other than the Participant exercises the SARs, then such person must submit documentation reasonably acceptable to the Company verifying that such person has the legal right to exercise the SARs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Date of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The SARs shall be deemed to be exercised on the business day that the Company receives a fully executed exercise notice. If the notice is received after business hours on such date, then the SAR shall be deemed to be exercised on the business date immediately following the business date such notice is received by the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Prior to the payment of the Appreciation Value in connection with the exercise of the SARs, the Participant must make arrangements satisfactory to the Company to pay or provide for any applicable federal, state and local withholding obligations of the Company. If approved by the Committee in its discretion, the required withholding obligations may be settled by the delivery to the Company of previously owned and unencumbered shares of Common Stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Form of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon the exercise of all or a portion of the SARs, the Participant shall be entitled to a cash payment equal to the Appreciation Value of the SARs being exercised, less any amounts withheld pursuant to <a href="#icb5ebeaff1154e31a7d30f095b70e7ed_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>5.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Section 409A&#59; No Deferral of Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Plan nor this Agreement is intended to provide for the deferral of compensation within the meaning of Section 409A of the Internal Revenue Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Company reserves the right to unilaterally amend or modify the Plan or this Agreement, to the extent the Company considers it necessary or advisable, in its sole discretion, to comply with, or to ensure that the SARs granted hereunder are not subject to, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">No Right to Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Plan nor this Agreement shall confer upon the Participant any right to be retained in any position, as an Employee, Consultant or Director of the Company. Further, nothing in the Plan or this Agreement shall be construed to limit the discretion of the Company to terminate the Participant&#8217;s Continuous Service at any time, with or without Cause. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The SARs are not transferable by the Participant other than to a designated beneficiary upon the Participant&#8217;s death or by will or the laws of descent and distribution, and are exercisable during the Participant&#8217;s lifetime only by him or her. No assignment or transfer of the SARs, or the rights represented thereby, whether voluntary or involuntary, by operation of law or otherwise (except to a designated beneficiary upon death by will or the laws of descent or distribution) will vest in the assignee or transferee any interest or right herein whatsoever, but immediately upon such assignment or transfer the SARs will terminate and become of no further effect.</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Effect on SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If a Change in Control occurs and the Participant&#8217;s Continuous Service is terminated by the Company without Cause (other than for death or Disability) or by the Participant for Good Reason, in either case, within twelve (12) months following the Change in Control, 100% of the SARs shall become immediately vested and exercisable.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Cash-out</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event of a Change in Control, the Committee may, in its discretion and upon at least ten (10) days&#8217; advance notice to the Participant, cancel the SARs and pay to the Participant the Appreciation Value of the SARs based upon the price per share of Common Stock received or to be received by other shareholders of the Company in the event. Notwithstanding the foregoing, if at the time of a Change in Control the Exercise Price of the SAR equals or exceeds the price paid for a share of Common Stock in connection with the Change in Control, the Committee may cancel the SAR without the payment of consideration therefor.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The SARs may be adjusted or terminated in any manner as contemplated by Section 14 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Tax Liability and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other tax-related withholding (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the ultimate liability for all Tax-Related Items is and remains the Participant&#8217;s responsibility and the Company (a) makes no representation or undertakings regarding the treatment of any Tax-Related Items in connection with the grant, vesting, or exercise of the SARs and (b) does not commit to structure the SARs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The exercise of the SARs shall be subject to compliance by the Company and the Participant with all Applicable Laws, including the requirements of any stock exchange on which the Company&#8217;s shares of Common Stock may be listed. The Participant may not exercise the SARs if such exercise would violate any applicable Federal or state securities laws or other laws or regulations. The Participant understands that the Company is under no obligation to register the shares of Common Stock with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the Secretary of the Company at the Company&#8217;s principal corporate offices. Any notice required to be delivered to the Participant under this Agreement shall be in writing and addressed to the Participant at the Participant&#8217;s address as shown in the records of the Company. Either party may designate another address in writing (or by such other method approved by the Company) from time to time.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement will be construed and interpreted in accordance with the laws of the State of Utah without regard to conflict of law principles.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In accordance with Section 17.2 of the Plan, by accepting the SARs, the Participant acknowledges that the Participant is fully bound by, and subject to, all of the terms and conditions of the Clawback Policy, and the Participant agrees to abide by the terms of the Clawback Policy. To the extent that the Board (or, if applicable, the Committee) determines that all or a portion of the SARs or the cash paid on exercise of the SARs must be cancelled, forfeited, repaid, or otherwise recovered by the Company, the Participant shall promptly take whatever action is necessary to effectuate such cancellation, forfeiture, repayment, or recovery. No recovery of all or a portion of the SARs or the cash paid on exercise of the SARs under the Clawback Policy will be an event giving rise to a right to terminate employment for Good Reason under any agreement with the Company. In the event of any conflict between the terms of the Clawback Policy and the terms of the Plan or this Agreement, the terms of the Clawback Policy shall govern.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any dispute regarding the interpretation of this Agreement shall be submitted by the Participant or the Company to the Committee for review. The resolution of such dispute by the Committee shall be final and binding on the Participant and the Company.</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">SARs Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is subject to the Plan as approved by the Company&#8217;s shareholders. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant&#8217;s beneficiaries, executors, administrators and the person(s) to whom the SARs may be transferred by will or the laws of descent or distribution.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Discretionary Nature of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan is discretionary and may be amended, cancelled or terminated by the Company at any time, in its discretion. The grant of the SARs in this Agreement does not create any contractual right or other right to receive any SARs or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Participant&#8217;s employment with the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee has the right to amend, alter, suspend, discontinue or cancel the SAR, prospectively or retroactively&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, no such amendment shall adversely affect the Participant&#8217;s material rights under this Agreement without the Participant&#8217;s consent. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">No Impact on Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The value of the Participant&#8217;s SARs is not part of his or her normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance or similar employee benefit.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by electronic mail in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the SARs subject to all of the terms and conditions of the Plan and this Agreement. The Participant acknowledges that there may be adverse tax consequences upon exercise of the SARs and that the Participant should consult a tax advisor prior to such exercise.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMPANY&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PARTICIPANT&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a104formofrestrictedstocku.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i599406914b5645388fdab99674d986bc_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Restricted Stock Unit Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) by and between USANA Health Sciences, Inc., a Utah corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and &#91;&#9679;&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company has adopted the USANA Health Sciences 2025 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) pursuant to which awards of Restricted Stock Units may be granted&#59; and</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Committee has determined that it is in the best interests of the Company and its shareholders to grant the award of Restricted Stock Units provided for herein.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Grant of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Pursuant to Section 8 of the Plan, the Company hereby issues to the Grantee on the Grant Date an Award consisting of, in the aggregate, &#91;&#9679;&#93; Restricted Stock Units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Each Restricted Stock Unit represents the right to receive one share of Common Stock, subject to the terms and conditions set forth in this Agreement and the Plan. Capitalized terms that are used but not defined herein have the meaning ascribed to them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Restricted Stock Units shall be credited to a separate account maintained for the Grantee on the books and records of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). All amounts credited to the Account shall continue for all purposes to be part of the general assets of the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The grant of the Restricted Stock Units is made in consideration of the services to be rendered by the Grantee to the Company. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Except as otherwise provided herein, provided that the Grantee remains in Continuous Service through the applicable vesting date, the Restricted Stock Units will vest in accordance with the following schedule (the period during which restrictions apply, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Date</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Number or Percentage of Restricted Stock Units That Vest</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#9679;&#93;</font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Once vested, the Restricted Stock Units become &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vested Units.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The foregoing vesting schedule notwithstanding, and subject to Section 13.1 of the Plan, if the Grantee&#8217;s Continuous Service terminates for any reason at any time before all of their Restricted Stock Units have vested, the Grantee&#8217;s unvested Restricted Stock Units shall be automatically forfeited upon such termination of Continuous Service and neither the Company nor any Affiliate shall have any further obligations to the Grantee under this Agreement.  </font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The foregoing vesting schedule notwithstanding, if a Change in Control occurs and the Grantee&#8217;s Continuous Service is terminated by the Company or an Affiliate without Cause or by the Grantee for Good Reason, and the Grantee&#8217;s date of termination occurs (or in the case of the Grantee&#8217;s termination of Continuous Service for Good Reason, the event giving rise to Good Reason occurs) within twelve (12) months following the Change in Control, all unvested Restricted Stock Units shall automatically become 100% vested on the Grantee&#8217;s date of termination.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to any exceptions set forth in this Agreement or the Plan, during the Restricted Period and until such time as the Restricted Stock Units are settled in accordance with <a href="#i599406914b5645388fdab99674d986bc_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>6, the Restricted Stock Units or the rights relating thereto may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee. Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the Restricted Stock Units or the rights relating thereto shall be wholly ineffective and, if any such attempt is made, the Restricted Stock Units will be forfeited by the Grantee and all of the Grantee&#8217;s rights to such units shall immediately terminate without any payment or consideration by the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Rights as Shareholder&#59; Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Grantee shall not have any rights of a shareholder with respect to the shares of Common Stock underlying the Restricted Stock Units unless and until the Restricted Stock Units vest and are settled by the issuance of such shares of Common Stock. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Upon and following the settlement of the Restricted Stock Units, the Grantee shall be the record owner of the shares of Common Stock underlying the Restricted Stock Units unless and until such shares are sold or otherwise disposed of, and as record owner shall be entitled to all rights of a shareholder of the Company (including voting rights). </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">If, prior to the settlement date, the Company declares a cash or stock dividend on the shares of Common Stock, then, on the payment date of the dividend, the Grantee&#8217;s Account shall be credited with Dividend Equivalents in an amount equal to the dividends that would have been paid to the Grantee if one share of Common Stock had been issued on the Grant Date for each Restricted Stock Unit granted to the Grantee as set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Company shall pay currently (and in no case later than the end of the calendar year in which the dividend is paid to the holders of the Common Stock or, if later, the 15th day of the third month following the date the dividend is paid to holders of Common Stock), in cash, an amount equal to the Dividend Equivalents with respect to the Grantee&#8217;s Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Settlement of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Subject to <a href="#i599406914b5645388fdab99674d986bc_1" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:none">Section </a>9 hereof, promptly following the vesting date, and in any event no later than March 15 of the calendar year following the calendar year in which such vesting occurs, the Company shall (a) issue and deliver to the Grantee the number of shares of Common Stock equal to the number of Vested Units&#59; and (b) enter the Grantee&#8217;s name on the books of the Company as the shareholder of record with respect to the shares of Common Stock delivered to the Grantee. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Notwithstanding Section 6.1, in accordance with Section 17.5 of the Plan, the Committee may, but is not required to, prescribe rules pursuant to which the Grantee may elect to defer settlement of the Restricted Stock Units. Any deferral election must be made in compliance with such rules and procedures as the Committee deems advisable. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Grantee is deemed a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, as determined by the Committee, at a time when the Grantee becomes eligible for settlement of the RSUs upon his &#8220;separation from service&#8221; within the meaning of Section 409A of the Code, then to the extent necessary to prevent any accelerated or additional tax under Section 409A of the Code, such </font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">settlement will be delayed until the earlier of&#58; (a) the date that is six months following the Grantee&#8217;s separation from service and (b) the Grantee&#8217;s death.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">To the extent that the Grantee does not vest in any Restricted Stock Units, all interest in such Restricted Stock Units (and any related Dividend Equivalents) shall be forfeited. The Grantee has no right or interest in any Restricted Stock Units that are forfeited.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">No Right to Continued Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Plan nor this Agreement shall confer upon the Grantee any right to be retained in any position, as an Employee, Consultant or Director of the Company. Further, nothing in the Plan or this Agreement shall be construed to limit the discretion of the Company to terminate the Grantee&#8217;s Continuous Service at any time, with or without Cause. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If any change is made to the outstanding Common Stock or the capital structure of the Company, if required, the Restricted Stock Units shall be adjusted or terminated in any manner as contemplated by Section 14 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Tax Liability and Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">The Grantee shall be required to pay to the Company, and the Company shall have the right to deduct from any compensation paid to the Grantee pursuant to the Plan, the amount of any required withholding taxes in respect of the Restricted Stock Units and to take all such other action as the Committee deems necessary to satisfy all obligations for the payment of such withholding taxes. The Committee may permit the Grantee to satisfy any federal, state or local tax withholding obligation by any of the following means, or by a combination of such means&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">tendering a cash payment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable or deliverable to the Grantee as a result of the vesting of the Restricted Stock Units&#59; provided, however, that no shares of Common Stock shall be withheld with a value exceeding the maximum amount of tax required to be withheld by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">delivering to the Company previously owned and unencumbered shares of Common Stock.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Notwithstanding any action the Company takes with respect to any or all income tax, social insurance, payroll tax, or other tax-related withholding (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the ultimate liability for all Tax-Related Items is and remains the Grantee&#8217;s responsibility and the Company (a) makes no representation or undertakings regarding the treatment of any Tax-Related Items in connection with the grant, vesting or settlement of the Restricted Stock Units or the subsequent sale of any shares&#59; and (b) does not commit to structure the Restricted Stock Units to reduce or eliminate the Grantee&#8217;s liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The issuance and transfer of shares of Common Stock shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Company&#8217;s shares of Common Stock may be listed. No shares of Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the Secretary of the Company at the Company&#8217;s principal corporate offices. Any notice required to be delivered to the Grantee under this Agreement shall be in writing and addressed to the Grantee at the Grantee&#8217;s address as shown in the records of the Company. Either party may designate another address in writing (or by such other method approved by the Company) from time to time.</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement will be construed and interpreted in accordance with the laws of the State of Utah without regard to conflict of law principles.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Clawback</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In accordance with Section 17.2 of the Plan, by accepting the Restricted Stock Units, the Grantee acknowledges that the Grantee is fully bound by, and subject to all of the terms and conditions of, the Clawback Policy, and the Grantee agrees to abide by the terms of the Clawback Policy. To the extent that the Board (or, if applicable, the Committee) determines that all or any portion of the Restricted Stock Units or the shares of Common Stock issued on settlement thereof (or the value of those shares) must be cancelled, forfeited, repaid, or otherwise recovered by the Company, the Grantee shall promptly take whatever action is necessary to effectuate such cancellation, forfeiture, repayment, or recovery. No recovery of all or a portion of the Restricted Stock Units under the Clawback Policy will be an event giving rise to a right to resign for Good Reason under any agreement with the Company. In the event of any conflict between the terms of the Clawback Policy and the terms of the Plan or this Agreement, the terms of the Clawback Policy shall govern.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any dispute regarding the interpretation of this Agreement shall be submitted by the Grantee or the Company to the Committee for review. The resolution of such dispute by the Committee shall be final and binding on the Grantee and the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Restricted Stock Units Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is subject to the Plan as approved by the Company&#8217;s shareholders. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee and the Grantee&#8217;s beneficiaries, executors, administrators and the person(s) to whom the Restricted Stock Units may be transferred by will or the laws of descent or distribution.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The invalidity or unenforceability of any provision of the Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Plan or this Agreement, and each provision of the Plan and this Agreement shall be severable and enforceable to the extent permitted by law.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Discretionary Nature of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan is discretionary and may be amended, cancelled or terminated by the Company at any time, in its discretion. The grant of the Restricted Stock Units in this Agreement does not create any contractual right or other right to receive any Restricted Stock Units or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company. Any amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Grantee&#8217;s employment with the Company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee has the right to amend, alter, suspend, discontinue or cancel the Restricted Stock Units, prospectively or retroactively&#59; provided, that, no such amendment shall adversely affect the Grantee&#8217;s material rights under this Agreement without the Grantee&#8217;s consent. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance with Section 409A of the Code. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">No Impact on Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The value of the Grantee&#8217;s Restricted Stock Units is not part of his or her normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance or similar employee benefit.</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by facsimile transmission, by electronic mail in portable document format (.pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing an original signature.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.25pt;text-decoration:underline">Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Grantee hereby acknowledges receipt of a copy of the Plan and this Agreement. The Grantee has read and understands the terms and provisions thereof, and accepts the Restricted Stock Units subject to all of the terms and conditions of the Plan and this Agreement. The Grantee acknowledges that there may be adverse tax consequences upon the vesting or settlement of the Restricted Stock Units or disposition of the underlying shares and that the Grantee has been advised to consult a tax advisor prior to such vesting, settlement or disposition.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMPANY&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">USANA Health Sciences, Inc.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GRANTEE&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>usna-20250519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:80c088a4-b4c3-4c05-b0b3-83b9966e8538,g:2cbdd6ee-3145-418e-a011-edf93e12ee88-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:usna="http://www.usana.com/20250519" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.usana.com/20250519">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="usna-20250519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="usna-20250519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.usana.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>usna-20250519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:80c088a4-b4c3-4c05-b0b3-83b9966e8538,g:2cbdd6ee-3145-418e-a011-edf93e12ee88-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_8e6f6096-fe35-4b6a-beeb-dfa6ee742a4c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_242cb63f-e874-4bc6-94e0-d73e7a2adb77_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c8776cd4-3c4c-4bcc-afed-c13c22f68fff_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2ef93e22-414c-4765-8889-024b5fd3c901_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e17aac4b-fb14-48ad-ab5e-bf584984825c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_aeb1d8e6-3ea9-4cb4-9a4b-44e7d7720246_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e2f8e157-377f-42b7-ba72-3f34a6967ab4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_959648bc-27d8-4a77-b89d-a95797f0c33d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e7b1567b-4c71-494e-9c15-a5112165362c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8a7808de-c444-4035-bb7c-8340b9c7f3f1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d577eb39-5ad0-49b8-9ae4-998934648112_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_0e9b681c-2a84-46f9-baa4-ebcf2d0e563b_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5ad54128-452c-484c-ae49-7a80356b4c5c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3a64c3a7-0a99-4551-9269-d313bf852400_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a61db038-9292-4583-80a1-79edb7ab9b02_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ecf3f1e9-db1e-4896-808a-66e2d862c375_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ae8473fc-8dc7-44f5-a608-f08f79915918_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1a367cee-e378-4aa3-92df-cd088ab8a4f8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_16e6a61b-2433-4862-8baa-00cc9c7ea1f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_769cfbfa-9f85-4ab3-af0e-54d1c8367c50_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bca507cc-5dcc-4386-b97d-991f99bb26bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f8c28e5a-5ce2-4140-b7ac-d7c9e58a199f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>usna-20250519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:80c088a4-b4c3-4c05-b0b3-83b9966e8538,g:2cbdd6ee-3145-418e-a011-edf93e12ee88-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.usana.com/role/Cover" xlink:type="simple" xlink:href="usna-20250519.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.usana.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_05d0c5b1-a3ff-4ad1-ba95-eabccb18860b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_DocumentType_05d0c5b1-a3ff-4ad1-ba95-eabccb18860b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6435fde4-e8d1-4189-9f8a-c36851c70945" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_DocumentPeriodEndDate_6435fde4-e8d1-4189-9f8a-c36851c70945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9ce96161-a9fe-49a6-a208-101b6294e69a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityRegistrantName_9ce96161-a9fe-49a6-a208-101b6294e69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e4e44cbd-18b5-43c9-982d-19dd9f7e0484" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e4e44cbd-18b5-43c9-982d-19dd9f7e0484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c4d1ceca-cf9f-41af-8131-84cd7c22a5ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityFileNumber_c4d1ceca-cf9f-41af-8131-84cd7c22a5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8d30b4db-fa5d-420a-9158-8ba8e32e9fe4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityTaxIdentificationNumber_8d30b4db-fa5d-420a-9158-8ba8e32e9fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c51f01a8-cb33-4cd6-b4a1-2fa1a386ec62" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityAddressAddressLine1_c51f01a8-cb33-4cd6-b4a1-2fa1a386ec62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7412182a-8a00-4e20-b248-cdbad35d73fe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityAddressCityOrTown_7412182a-8a00-4e20-b248-cdbad35d73fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_057b18d2-40ae-4cfb-b3a6-3ff7ef786cc4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityAddressStateOrProvince_057b18d2-40ae-4cfb-b3a6-3ff7ef786cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a0685b0-5b7f-4663-bd89-ac5550cecd3d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityAddressPostalZipCode_6a0685b0-5b7f-4663-bd89-ac5550cecd3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0049c7ab-cca6-4fc8-889a-6cafd27314b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_CityAreaCode_0049c7ab-cca6-4fc8-889a-6cafd27314b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6c63dcc3-7440-4a4f-882a-bf5c590a4d65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_LocalPhoneNumber_6c63dcc3-7440-4a4f-882a-bf5c590a4d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_61c890ae-5d87-4657-959b-fc48b4f3466a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_WrittenCommunications_61c890ae-5d87-4657-959b-fc48b4f3466a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_6f825d62-c603-4319-9aef-dee2657279f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_SolicitingMaterial_6f825d62-c603-4319-9aef-dee2657279f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_849efc52-b16b-4750-9f25-40ec98414158" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_PreCommencementTenderOffer_849efc52-b16b-4750-9f25-40ec98414158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f4731db6-61e5-46d8-af59-f21ef104fe13" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f4731db6-61e5-46d8-af59-f21ef104fe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_599f5456-d656-4079-8bca-01f0a7d47b01" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_Security12bTitle_599f5456-d656-4079-8bca-01f0a7d47b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_03f07c14-6826-4a51-bd12-9b69e9d7bd52" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_TradingSymbol_03f07c14-6826-4a51-bd12-9b69e9d7bd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1b317255-0ef1-438a-ab41-aa71148c9cee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_SecurityExchangeName_1b317255-0ef1-438a-ab41-aa71148c9cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_85daa921-4621-414a-b7ad-8d155efeb3f1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityEmergingGrowthCompany_85daa921-4621-414a-b7ad-8d155efeb3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d80db40e-7d7f-438d-9adc-bad3d80e4a27" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_AmendmentFlag_d80db40e-7d7f-438d-9adc-bad3d80e4a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d96d0b99-7d53-4a7f-9b3f-9a819925540f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5de6b36f-c120-4e42-80d4-134d5abff33d" xlink:to="loc_dei_EntityCentralIndexKey_d96d0b99-7d53-4a7f-9b3f-9a819925540f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">USANA HEALTH SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0500306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3838 West Parkway Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">954-7100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">USNA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000896264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="usna-20250519.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.usana.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="usna-20250519.htm">usna-20250519.htm</File>
    <File>usna-20250519.xsd</File>
    <File>usna-20250519_lab.xml</File>
    <File>usna-20250519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "usna-20250519.htm": {
   "nsprefix": "usna",
   "nsuri": "http://www.usana.com/20250519",
   "dts": {
    "inline": {
     "local": [
      "usna-20250519.htm"
     ]
    },
    "schema": {
     "local": [
      "usna-20250519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "usna-20250519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "usna-20250519_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.usana.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "usna-20250519.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "usna-20250519.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.usana.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000896264-25-000144-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000896264-25-000144-xbrl.zip
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ME8*DTE%W/=!J5VJG_3*ZZ[UUU1?8&7[-5U^@A&DQE;!H<_F6J=ZB' +\!HL
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MW&4L]D)]3!?-8O-Y[)D*8DB8@&K"QH&*D-X:U/U/:16#Y?/?6I4FD=B;D<'
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M!_#YH$)NL>YP>85':7-NU V;U!1YV_)>_FTFH!WSJLEJK/@D7>4@>URS@/1
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MAB<> :?2:*.RZ^5O+3)^I/1'JG%LODD:=#!0&9<8M!/YU5Y/ _A+E]Q,2IS
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M'AVM8N-%E QL\*BSTPIY7G%3P3,RG=SR+T1,8H.\A(FFU"2\!$=@LT(1"IM
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MB^P(E_NS0C JN-PW+W[G(\ZY^3YTH1_F$B*TV.>3Q*"?BO$(&L#N+5<4T#@
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M5"FI7"2%J8?#.N-#=;5B!1ZZX <O3W* %N@Q+I(B%Y<JN];PIC&H[/)>*E!
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M$MAH!+GU6WX4*L79\H  G^]XV3^LST#%Z%Q E8&U*I.:IQI\BY,YE?"U=+B
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MY_#SXJ]GO:>C)%S /U,SB][^&U!+ P04    "  LD[-:[LL.#%D8   $M
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MTKK$SNTH%+,ZS.4^:#(XPRS*C+AE\;\O.LDX73(?BKC<)K&,PEDIYP758H=
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MR]&WB3G1@Z>0D;H.@ONK38G>5-8",J^@_,J]13&N%L+:$BYMT;"3;6: F+D
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M[0?X:!'C-(MF91HE!?7;W*G<NEWXQ>T-)=#UBQU<#K%.2J*]I9JD614Z^?,
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M>8L0EVH!CR9=ILX1+@?646%BI](=#T_=>C??% ,#DITB6#P1'@(K3.KU"F7
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MEC/[WS%H=?37!ZU>#50\@Q_C?)*\_7]02P,$%     @ +).S6LK580UD%0
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MT6-2'PQ"'L0R!0=/YM]#(\B"B$+Q$:D+@>J"I:-%Q><'N.5[BU\!PCF],DR
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MZE)J53*K2U>3BS!3M=KPH+05>F19"_1(?KDU>O3":O2Z-,E<5B.$GI!+>L-
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M'7#K=C* M!<!1X:LV\XN7SWC^M!JSKB&\?O9J^TSZ?K3*L]>_0]02P,$%
M  @ +).S6MQ\OA*P!@  V#   !4   !U<VYA+3(P,C4P-3$Y7W!R92YX;6S5
M6EUSV[82??>O4-77"PL  1#PQ.[XNDG'<]W&D[C33E\T^%A(G%*D!Z1C^]_?
M)6TE<6SW\IJ:,?.B#Q+DV3U[M-A=ZLU/-YMR]@E24]35X9SMT_D,*E^'HEH=
MSG^_>$?T_*>CO;TW/Q#RY[\_G,U^KOW5!JIV=I+ MA!FUT6[GK5KF/U1I[^+
M3W9V7MHVUFE#R%%_V4E]>9N*U;J=<<KE=MGV;#K0U%.MK2!.^(P(3R5QU&5$
M9\X8I4#+3/]K=<"]"T$!D(P)20330"QEC$"()@/& ;3N;UH6U=\'W8NS#<S0
MO:KIOQ[.UVU[>;!87%]?[]^X5.[7:;7@E&:+[>KY_?*;1^NOLWXU,\8L^K.?
MES;%4POQMFSQYZ]G'_T:-I845=/:RG< 37'0] ?/:F_;GO7_:=?LV17=-[)=
M1KI#A'&D:/^F"?.CO=GLCHY4E_ !XJQ[__W#Z0/(J\96=M_7FT5W=G%2HQK0
MSOZZ]O82#N=-L;DL87MLG2 >SJ^:RI(NH%0RTZ']>'?AX@OH98(&E=([>88'
M[J_O4/Y/ ^"FA2K G4?;VY>U?["H[/BL/U]96@=E?W09H%CV=SUV39NL;Y<R
M@'*9BL0S3HD P8FF01"6B2"MBS'+PD-_.WL;-+BGOP&_OZH_+?#&& :>=1\Z
M,K*>B$=P=Z2\S.[M[^T"URZI#-1+QXC-8B3"!D:<-9* ==X[IK6B;I397Z,]
MM/KK8!XG/ZM3@(0)8PMGDW\4V(=2O5^QN+0);T3\NB@_<QQ3O=E%K-IZ!\S=
MA07-G<_0ZP@I03B[B\JSSO6>M9A&H5^YBXB?0RKJ\+8*/V.>72J1R1A $-!H
M.Z8_0TS4EOA,:<E\3HV0.PG] ]A!&N#3U\#+N7QE,;RMVJ*]_0"KHF.B:G^S
M&U@:#T8QA6(V$8@P5A'+J2:,,J>X$:",':6%IU '22&;KA1&,SD))9QB;98N
MZ]03_Q'YAY/ZJFK3[4D=8 E(A\ ZB3#ML$;*/ I;<_QJ0C Q!RJTV($P_M&(
M03H14]?)[GB>A&S>%27\=K5QD)9>!.;!8[:+!G="9B/1+&-$"Q]RS[F5%G:@
MD2^(@P0AIRZ(%S(XB>A?V)O3@%P5L;AK.>X=T2&C3@1'HI6!"$XM,4QJHIW5
MD'' G+B+=/$,_"!=J*GK8A?<3D(DQR%@")K[-^S7@"V]9)$RJXEW6=>:!X5-
MNF6$1\MLIA5XQ7<@D">@!XDCG[HXQG(Z)6&<X,?WZ:*^KI:Y8)QI;HFVM",%
MF7%<H$?!V9#)D&=Q%UO((^!!HM#?B2A>R.>4)-'71>_3>:H_%97OFNP<6^G
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M"U!+ 0(4 Q0    ( "R3LUIK!2$<ZUL  ";' @ >              "  0
M  !A,3 Q=7-A;F%H96%L=&AS8VEE;F-E<VEN8RYH=&U02P$"% ,4    "  L
MD[-:<RM_"4D9  "KK@  '@              @ $G7   83$P,F9O<FUO9G!E
M<F9O<FUA;F-E<VAA<F4N:'1M4$L! A0#%     @ +).S6N[+#@Q9&   !+0
M !X              ( !K'4  &$Q,#-F;W)M;V9S=&]C:V%P<')E8VEA=&EO
M+FAT;5!+ 0(4 Q0    ( "R3LUK#EIB;AQH  (2Z   >              "
M 4&.  !A,3 T9F]R;6]F<F5S=')I8W1E9'-T;V-K=2YH=&U02P$"% ,4
M"  LD[-:RM5A#605  "_S   $0              @ $$J0  =7-N82TR,#(U
M,#4Q.2YH=&U02P$"% ,4    "  LD[-:;53GG%T"  #P!@  $0
M    @ &7O@  =7-N82TR,#(U,#4Q.2YX<V102P$"% ,4    "  LD[-:3IJ3
M!00*  !]5   %0              @ $CP0  =7-N82TR,#(U,#4Q.5]L86(N
M>&UL4$L! A0#%     @ +).S6MQ\OA*P!@  V#   !4              ( !
M6LL  '5S;F$M,C R-3 U,3E?<')E+GAM;%!+!08     "  ( #0"   ]T@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>usna-20250519_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="usna-20250519.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000896264</identifier>
        </entity>
        <period>
            <startDate>2025-05-19</startDate>
            <endDate>2025-05-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0000896264</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">USANA HEALTH SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-35024</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">87-0500306</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3838 West Parkway Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">84120</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">954-7100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">USNA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
